A potential biomarker for the efficacy of complement inhibitors in myasthenia gravis. Ogaya E, Uzawa A, Akamine H, Yasuda M, Handa H, Kurumada K, Takasaka K, Masuda H, Mori M, Kuwabara S J Neurol Sci. 2026 Oct 10; 491:126212. PMID: 42868840. Abstract CommentRecommendBookmarkWatch